sitagliptin phosphate 100 MG Oral Tablet [Januvia]
RxNorm concept 665036, branded drug (sbd). Prescribable name: Januvia 100 MG Oral Tablet.
- RxCUI
- 665036
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/665036 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Januvia 100 MG (as SITagliptin phosphate monohydrate 128.5 MG) Oral Tablet; Januvia 100 MG (as sitagliptin phosphate monohydrate 128.5 MG) Oral Tablet; SITagliptin phosphate 100 MG Oral Tablet [Januvia]
Related concepts
- sitagliptin phosphate 100 MG (SCDC, consists of)
- sitagliptin phosphate 100 MG [Januvia] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Januvia (BN, has ingredient)
- sitagliptin phosphate 100 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00006027701
- 00006027702
- 00006027714
- 00006027728
- 00006027731
- 00006027733
- 00006027754
- 00006027782
- 50090103600
- 50090103602
- 50090408400
- 50090558500
- 50090558501
- 55154504208
- 58118027703
- 58118027706
- 58118027709
- 66105065203
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 665036 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/665036 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 665036. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.